Literature DB >> 17470835

Treatment of polymyalgia rheumatica and giant cell arteritis: are we any further forward?

Raashid Luqmani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17470835     DOI： 10.7326/0003-4819-146-9-200705010-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

Review 1.  The treatment of giant cell arteritis.

Authors:  J Alexander Fraser; Cornelia M Weyand; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2008

2.  Treatment of vision loss in giant cell arteritis.

Authors:  Ryan A Scheurer; Andrew R Harrison; Michael S Lee
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

Review 3.  In vivo tumor secretion probing via ultrafiltration and tissue chamber: implication for anti-cancer drugs targeting secretome.

Authors:  Chun-Ming Huang; Teruaki Nakatsuji; Yu-Tseung Liu; Yang Shi
Journal:  Recent Pat Anticancer Drug Discov       Date:  2008-01       Impact factor: 4.169

Review 4.  An approach to the diagnosis and management of systemic vasculitis.

Authors:  A Miller; M Chan; A Wiik; S A Misbah; R A Luqmani
Journal:  Clin Exp Immunol       Date:  2010-01-12       Impact factor: 4.330

5.  Response to 'Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial'.

Authors:  Pippa Watson; Hill Gaston
Journal:  Arthritis Res Ther       Date:  2011       Impact factor: 5.156

6.  Optimal management of giant cell arteritis and polymyalgia rheumatica.

Authors:  Rodger Charlton
Journal:  Ther Clin Risk Manag       Date:  2012-04-05       Impact factor: 2.423
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.